Independent Insights, a Health Mart Podcast

Health Mart
  • 5.0 (11)
  • COURSES
  • UPDATED WEEKLY

Independent Insights, a Health Mart Podcast brings together independent pharmacy owners and other community pharmacy experts to inspire all pharmacy team members to not just survive, but thrive in building practices that cater to the needs of local communities. Plug in to hear ways to innovate patient care services and strengthen the overall health of your pharmacy business.    Plus, sharpen your clinical skills with GameChangers Clinical Conversations - a weekly pharmacotherapy podcast featuring the latest game-changing advances in patient care. New episodes arrive every Monday and are available for CE credit. Check the show notes for instructions on how to redeem your credit.   Happy listening!

  1. Updates in HIV PEP Protocols and Guidelines

    4D AGO

    Updates in HIV PEP Protocols and Guidelines

    Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP decision‑making, patient counseling, and care coordination. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Kenric Ware, Pharm D Clinical Associate Professor of Pharmacy Practice Mercer University   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current guideline recommendations for initiating HIV PEP after occupational and non-occupational exposure. 2. Describe key considerations for selecting and managing HIV PEP regimens. Rachel Maynard and Kenric Ware have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-052-H01-P Initial release date: 2/16/2026 Expiration date: 2/16/2027 Additional CPE details can be found here.

    41 min
  2. Updates in HIV PrEP Therapy Options

    FEB 9

    Updates in HIV PrEP Therapy Options

    Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments, compares prevention strategies, and examines how these changes affect PrEP delivery, counseling, and monitoring. You will gain timely insights to better counsel patients, support adherence, and contribute to prevention strategies in your practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST David Hachey, PharmD, AAHIVP Professor  Idaho State University    Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe key new HIV PrEP therapy options recently approved or recommended, including their dosing schedules and clinical indications. 2. Identify pharmacist responsibilities when counseling patients about PrEP, including initiation, adherence, monitoring, and risk-benefit discussions.  Rachel Maynard and David Hachey have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-049-H01-P Initial release date: 2/9/2026 Expiration date: 2/9/2027 Additional CPE details can be found here.

    40 min
  3. The Role of Biosimilars in Managing Inflammatory Disease

    FEB 2

    The Role of Biosimilars in Managing Inflammatory Disease

    With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Reemal Zaheer, PharmD, CSP Pharmacist Johns Hopkins Medicine   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of biosimilars in the treatment of inflammatory conditions. 2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies. Rachel Maynard and Reemal Zaheer have no relevant financial relationships with ineligible companies to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-045-H01-P Initial release date: 2/2/2026 Expiration date: 2/2/2027 Additional CPE details can be found here.

    41 min

  4. JAN 28

    Episode 21: Inside NIAB – Shaping the Future of Independent Pharmacy

    Join us for a special live episode of Independent Insights as we sit down with members of the National Independent Advisory Board (NIAB), at McKesson ideaShare, to explore their vision for the future of pharmacy. Hear firsthand what they’ve learned from McKesson ideaShare (MiS), what excites them most about the road ahead, and how they’re working to elevate the voice of independent pharmacy across the country. Host Suzanne Feeney, PharmD Sr. Director, Pharmacy Solutions McKesson / Health Mart Guests Shelby Knott, PharmD Owner Warren Pharmacy Emmanuel Ayanjoke, PharmD Owner Altev Community Pharmacy Ghada Abukuwaik, RPh Owner Curemed Pharmacy  Resources Tune into Episode 16: Episode 16: Creating Pharmacy’s Future To listen to APhA President Randy McDonough and Chief Pharmacist Nancy Lyons as they discuss urgent changes and a bold vision for the future of independent pharmacy on this episode of Independent Insights.  References Listen to Episode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy. The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

    20 min
  5. FDA Removes Boxed Warnings on Menopausal Hormone Therapy

    JAN 26

    FDA Removes Boxed Warnings on Menopausal Hormone Therapy

    Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings for select hormone therapy (HT) products, the rationale for this change, and how evolving guidance may impact patient care. You will explore strategies to support evidence-based counseling and individualized decision-making for patients considering HT. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Erin Raney, PharmD Professor Midwestern University College of Pharmacy   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the FDA's updated position on boxed warnings for menopausal hormone therapy. 2. Identify key considerations for pharmacists when counseling patients about the benefits and risks of hormone therapy. Rachel Maynard and Erin Raney have no relevant financial relationships with ineligible companies to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-044-H01-P Initial release date: 1/26/2026 Expiration date: 1/26/2027 Additional CPE details can be found here.

    42 min
  6. Key Updates on the Return of Ranitidine

    JAN 19

    Key Updates on the Return of Ranitidine

    Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, reviews the reformulated product's changes (including manufacturing and labeling), and examines practical considerations for dispensing, counseling, and patient safety. You will gain clarity on when ranitidine may be appropriate for use (again) and how to guide patients confidently in its safe use. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST K. Ashley Garling-Nanez, PharmD Assistant Director of Program UT Center of Health Communications   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the major safety and regulatory issues that prompted ranitidine's withdrawal, and the changes made in the reformulated product approved in 2025. 2. Describe pharmacist‑relevant considerations for dispensing, patient counseling, and transition from alternative acid‑reducing therapies. Rachel Maynard and K. Ashley Garling-Nanez have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-043-H01-P Initial release date: 1/19/2026 Expiration date: 1/19/2027 Additional CPE details can be found here.

    32 min
  7. Measles And Whooping Cough Resurge

    JAN 12

    Measles And Whooping Cough Resurge

    Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the latest evidence on global and local trends, explores the factors driving renewed outbreaks, and discusses the key roles of pharmacists in prevention and early detection. You will gain insights to be better prepared to support immunization efforts, patient counseling, and public health awareness in response to this resurgence. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Christina O'Connor, PharmD, BCPS, BCIDP Clinical Pharmacy Manager Mayo Clinic   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent epidemiologic trends in pertussis and measles resurgence and factors contributing to increased incidence. 2. Identify the pharmacist's responsibilities for promoting vaccination, encouraging timely immunization, supporting outbreak prevention, and providing patient education. Rachel Maynard and Christina O'Connor have no relevant financial relationships to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-038-H01-P Initial release date: 1/12/2026 Expiration date: 1/12/2027 Additional CPE details can be found here.

    44 min
  8. The Great Debate of Steroid Use in CAP

    JAN 5

    The Great Debate of Steroid Use in CAP

    Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP and the other urging caution—offering pharmacists a balanced view of the current evidence and practice considerations. Tune in to explore both sides of the debate and walk away with insights to inform your role in collaborative patient care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUESTS Sam Markle, PharmD Critical Care Pharmacist Sanford Health Tristan Houle, PharmD PGY2 Critical Care Pharmacy Resident Sanford Health   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current evidence supporting and challenging the use of corticosteroids in the treatment of community-acquired pneumonia (CAP). 2. Identify key considerations for pharmacists when evaluating corticosteroid use as adjunctive therapy in CAP. Rachel Maynard, Sam Markle, and Tristan Houle have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-032-H01-P Initial release date: 1/5/2026 Expiration date: 1/5/2027 Additional CPE details can be found here.

    37 min
See All (118)

5
out of 5
11 Ratings

About

Independent Insights, a Health Mart Podcast brings together independent pharmacy owners and other community pharmacy experts to inspire all pharmacy team members to not just survive, but thrive in building practices that cater to the needs of local communities. Plug in to hear ways to innovate patient care services and strengthen the overall health of your pharmacy business.    Plus, sharpen your clinical skills with GameChangers Clinical Conversations - a weekly pharmacotherapy podcast featuring the latest game-changing advances in patient care. New episodes arrive every Monday and are available for CE credit. Check the show notes for instructions on how to redeem your credit.   Happy listening!

Information